Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 31. May. 2018 However, the role of the immune system in atherosclerosis appears to be more complex than in classical autoimmune diseases, and a number of protective immune responses has also been identified. One of the most important of these is carried out by the regulatory T cells. Regulatory T cells inhibit the development of autoimmunity by controlling the activity of autoreactive T cells. If the function of regulatory T cells is compromised in hypercholesterolemic mouse models of atherosclerosis, the development of disease becomes much more aggressive. In this review we will discuss the possibility that the inflammatory activity in atherosclerotic lesions depends on the balance between plaque antigen-specific pro-inflammatory Th1-type T cells and anti-inflammatory regulatory T cells specific for the same antigen. We will also discuss the role of hypercholesterolemia in generation of these modified self antigens as well as ongoing research aiming to develop novel immune-modulating therapy for prevention of cardiovascular disease by targeting these processes. 3 Inflammation plays a key role at all stages of the atherosclerotic disease process. In early lesions chemokines and adhesion molecules expressed by endothelial cells recruit inflammatory cells to the arterial intima. If the acute arterial inflammatory response does not resolve and macrophages and T cells continue to accumulate in the intima this will eventually lead to activation of a fibrotic repair process and development of raised fibromusclular lesions (Hansson 2005 ). This process is driven by intimal leukocytes that secrete cytokines and growth factors which stimulate medial smooth muscle cells to differentiate into a fibroblast-like phenotype and migrate to the intima, where they proliferate and produce extracellular matrix proteins. However, from a more clinical perspective the most important feature of inflammation in atherosclerosis is in the advanced lesion where matrix metalloproteinases secreted from activated macrophages may degrade the connective tissue in the fibrous cap causing plaque rupture.
It was initially believed that inflammation in atherosclerosis was caused solely by lipids (primarily oxidized LDL) directly interacting with proinflammatory signal pathways in vascular cells and monocytes/macrophages. Subsequent studies have also confirmed the importance of these mechanisms by demonstrating that mice lacking key components of innate immune signaling, such as Toll-like receptors 2 and 4 as well as their signaling 4 protein Myd 88, develop less vascular inflammation and atherosclerosis in response to hypercholesterolemia (Bjorkbacka et al. 2004 Michelsen et al. 2004 ).
However, it has also become clear that the regulation of inflammation in atherosclerosis is much more complex, and recent research has demonstrated that adaptive immune responses are of equal importance (Hansson and Libby 2006) . One concept that has emerged from these studies is that atherosclerosis to some extent can be viewed as an autoimmune disease in which the adaptive immune system is targeted against vascular self-antigens modified by hypercholesterolemia (Nilsson and Hansson 2008) . In this respect, atherosclerosis shares some similarities with other diseases considered to be of partial autoimmune etiology, such type I diabetes and rheumatoid arthritis. However, the role of the immune system appears to be even more complex in atherosclerosis, because there is evidence that the autoimmune responses evoked by hypercholesterolemia also may have protective effects. Moreover, acute myocardial infarction does not show the same association with a restricted number of HLA types as type I diabetes and rheumatoid arthritis, suggesting the involvement of multiple rather than 5 single autoantigens (Björkbacka et al 2010) . The major immune pathways of importance in the development of atherosclerosis are outlined in Figure 1 .
The evolving understanding of the importance of the balance between protective and disease-promoting autoimmunity in atherosclerosis has also stimulated the development of novel therapies, such as vaccines, that may be used to selectively modulate these immune processes. A particularly interesting target for such therapies is the regulatory T cell (Treg), which has been attributed a critical role in controlling the development of immune responses against self antigens. It this review we will discuss the role of Tregs in controlling autoimmune responses induced by hypercholesterolemia and the possibility to selectively activate Tregs in an antigen-specific manner by vaccines.
Autoimmunity against antigens induced by hypercholesterolemia promotes atherosclerosis
The first evidence for involvement of autoimmune responses in atherosclerosis was discovered more than 20 years ago when Jonasson and coworkers demonstrated expression of MHC class II antigen as well as the presence of activated T cells in human atherosclerotic plaques (Jonasson et 6 al. 1985) . Findings from initial studies using hypercholesterolemic mice deficient in all lymphocytes (resulting from Rag or SCID gene mutations)
were not entirely conclusive and suggested a role for immunity primarily in animals with a low cholesterol challenge (Zhou et al. 2000 Reardon et al. 2001 ). Detailed phenotyping of T cells in human plaques revealed that these primarily were of the pro-inflammatory Th1 type (Frostegard et al. 1999 ). Major and colleagues (Major et al., 2002) demonstrated that B cell deficiency in Ldlr -/-mice was associated with a 30-40% increase in 7 atherosclerosis (Major et al. 2002) . It has also been shown that the more aggressive atherosclerosis that characterizes splenectomized mice can be reversed by B cell reconstitution (Caligiuri et al. 2002) . The latter observations were of particular importance because they represented some of the first evidence of the existence of protective immunity in atherosclerosis.
Subsequent animal studies in which LDL receptor-deficient (Ldlr
-/-) or apolipoprotein E-deficient (ApoE -/-) mice
Oxidized LDL is a major autoantigen in atherosclerosis
The circumstance that the experimental studies describing the pathogenic role of Th1 immunity in atherosclerosis were based on induction of disease by hypercholesterolemia suggests that the relevant autoantigen is a lipoprotein or possibly a protein modified by lipids. Most attention has focused on the role of oxidized LDL in these processes. Antibodies against oxidized LDL are common in humans (Hulthe 2004) . Oxidized LDL, as well as oxidized LDL autoantibodies, have also been isolated from atherosclerotic plaques (Yla-Herttuala et al. 1994) . T cells specifically recognizing epitopes in oxidized LDL are present in the circulation and are enriched in human atherosclerotic lesions (Stemme et al. 1995) . Collectively these studies provide strong evidence for the existence of autoimmune responses against oxidized LDL.
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Paradoxically, it was studies evaluating the functional role of autoimmunity against oxidized LDL that first revealed the existence of athero-protective immune responses. We and others found that hypercholesterolemic rabbits immunized with oxidized LDL unexpectedly developed a partial protection against atherosclerosis (Palinski et al. 1995; Ameli et al. 1996) . Similar observations were subsequently made in mouse models of atherosclerosis (George et al. 1998 Zhou et al. 2001 ).
Immune-modulation as a novel therapeutic approach for prevention of atherosclerosis
The finding that athero-protective immune responses could be activated by immunization with oxidized LDL pointed to the fascinating possibility of developing an atherosclerosis vaccine. Several laboratories initiated studies to reveal the active antigens in oxidized LDL and to characterize mechanisms involved in the protective effect. The result of these studies demonstrated the presence of multiple antigens related either to peptide fragments of B-100 (Fredrikson et al. 2003a) or to oxidized phospholipids (Binder et al., 2003) that, when incorporated into pilot vaccines significantly inhibited the development of atherosclerosis (Fredrikson et al. 2003b Chyu et al. 2005 . Unexpectedly, it was also found that part of the protective effect Initial studies suggested that this was also the case for oxidized LDL antigen-based vaccines. The protective effect of immunization can be transferred into non-immunized mice by transplantation of spleen cells (Chyu et al. 2005) , and it has been shown that the more aggressive development of atherosclerosis that occurs in splenectomized mice can be reversed by B cell substitution (Caligiuri et al. 2002) . Immunization with 10 apo B peptides results in generation of apo B peptide-specific antibodies, and high levels of antibodies against apo B peptides have been associated with less severe atherosclerosis and a lower risk for development of acute cardiovascular events in humans (Fredrikson et al. 2007 Sjogren et al. 2008 ).
Finally, treatment with recombinant antibodies specific for the aldehyde- immunization with apo B peptides may inhibit atherosclerosis also in the absence of a specific antibody response demonstrating that alternative mechanisms must exist. Ongoing studies in 11 several laboratories point to the regulatory T cells (Tregs) as the most likely candidate for this alternative protective immune pathway.
Tregs control autoimmunity
The most important function of the immune system is to recognize and eliminate infectious microorganisms. In doing so it is vital that the immune system can differentiate these pathogens from self antigens. However and their function appears to be compromised in patients with acute 14 coronary syndromes (Mor et al. 2006) . However, it has not been elucidated whether the decrease in Tregs is the cause or the consequence of the acute event.
Therapeutic targeting of Tregs
The identification of Tregs as an important protective factor in atherosclerosis has focused the attention on these cells as possible targets for intervention. As discussed above, there is accumulating evidence that the rate of progression of the disease is determined by the balance between pro- 
